Moderna, Inc. (MRNA)

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of $9.38 billion. The enterprise value is $1.73 billion.

Market Cap	9.38B
Enterprise Value	1.73B

Important Dates

The last earnings date was Thursday, May 1, 2025, before market open.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Moderna has 386.74 million shares outstanding. The number of shares has increased by 1.05% in one year.

Current Share Class	386.74M
Shares Outstanding	386.74M
Shares Change (YoY)	+1.05%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	6.59%
Owned by Institutions (%)	69.74%
Float	360.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.94
Forward PS	4.26
PB Ratio	0.93
P/TBV Ratio	0.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.22, with a Debt / Equity ratio of 0.07.

Current Ratio	4.22
Quick Ratio	3.92
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-196.26

Financial Efficiency

Return on equity (ROE) is -29.34% and return on invested capital (ROIC) is -18.75%.

Return on Equity (ROE)	-29.34%
Return on Assets (ROA)	-15.84%
Return on Invested Capital (ROIC)	-18.75%
Return on Capital Employed (ROCE)	-33.59%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.22
Inventory Turnover	27.39

Taxes

Income Tax	-49.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.11% in the last 52 weeks. The beta is 2.00, so Moderna's price volatility has been higher than the market average.

Beta (5Y)	2.00
52-Week Price Change	-80.11%
50-Day Moving Average	29.20
200-Day Moving Average	49.39
Relative Strength Index (RSI)	38.01
Average Volume (20 Days)	8,467,739

Short Selling Information

The latest short interest is 56.31 million, so 14.56% of the outstanding shares have been sold short.

Short Interest	56.31M
Short Previous Month	49.80M
Short % of Shares Out	14.56%
Short % of Float	15.60%
Short Ratio (days to cover)	5.72

Income Statement

In the last 12 months, Moderna had revenue of $3.18 billion and -$3.36 billion in losses. Loss per share was -$8.73.

Revenue	3.18B
Gross Profit	-2.62B
Operating Income	-3.73B
Pretax Income	n/a
Net Income	-3.36B
EBITDA	-3.54B
EBIT	-3.73B
Loss Per Share	-$8.73

Balance Sheet

The company has $5.98 billion in cash and $745.00 million in debt, giving a net cash position of $7.65 billion or $19.78 per share.

Cash & Cash Equivalents	5.98B
Total Debt	745.00M
Net Cash	7.65B
Net Cash Per Share	$19.78
Equity (Book Value)	10.07B
Book Value Per Share	26.01
Working Capital	5.16B

Cash Flow

In the last 12 months, operating cash flow was -$3.05 billion and capital expenditures -$972.00 million, giving a free cash flow of -$4.02 billion.

Operating Cash Flow	-3.05B
Capital Expenditures	-972.00M
Free Cash Flow	-4.02B
FCF Per Share	-$10.40

Margins

Gross margin is -82.37%, with operating and profit margins of -117.37% and -105.67%.

Gross Margin	-82.37%
Operating Margin	-117.37%
Pretax Margin	-107.21%
Profit Margin	-105.67%
EBITDA Margin	-111.33%
EBIT Margin	-117.37%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.05%
Shareholder Yield	-1.05%
Earnings Yield	-35.79%
FCF Yield	-42.91%

Analyst Forecast

The average price target for Moderna is $51.94, which is 114.19% higher than the current price. The consensus rating is "Hold".

Price Target	$51.94
Price Target Difference	114.19%
Analyst Consensus	Hold
Analyst Count	20
Revenue Growth Forecast (5Y)	20.65%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 7.39 and a Piotroski F-Score of 2.

Altman Z-Score	7.39
Piotroski F-Score	2